建新股份(300107) - 2021 Q2 - 季度财报

Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥293.06 million, a decrease of 4.99% compared to the same period last year[23]. - The net profit attributable to shareholders of the listed company was approximately ¥7.14 million, down 87.07% year-on-year[23]. - The net profit after deducting non-recurring gains and losses was approximately ¥4.22 million, a decline of 92.21% compared to the previous year[23]. - The net cash flow from operating activities was approximately ¥83.54 million, a decrease of 15.93% from the same period last year[23]. - The basic earnings per share were ¥0.0130, down 87.06% year-on-year[23]. - The total profit for the first half of 2021 was CNY 6,927,772.64, down from CNY 63,506,836.33 in the same period of 2020, indicating a decline of over 89%[158]. - The net profit for the first half of 2021 was CNY 7,144,319.58, compared to CNY 55,207,400.72 in the first half of 2020, reflecting a significant decline[158]. - The gross profit margin decreased, with operating costs rising to CNY 259,763,487.03 from CNY 218,666,308.62, indicating a 19% increase in costs[160]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥1.58 billion, a decrease of 1.18% from the end of the previous year[23]. - The net assets attributable to shareholders of the listed company were approximately ¥1.43 billion, down 3.22% from the previous year[23]. - At the end of the reporting period, cash and cash equivalents amounted to ¥615,750,566.04, representing 39.02% of total assets, a decrease of 12.79% compared to the previous year[48]. - Accounts receivable increased to ¥93,925,614.72, accounting for 5.95% of total assets, up by 2.65% from the previous year[48]. - Inventory decreased to ¥79,557,509.24, making up 5.04% of total assets, down by 1.90% compared to the previous year[48]. - The total liabilities were not specified in the provided data, but the accounts payable decreased to CNY 35,743,997.53 from CNY 50,887,151.55, indicating a reduction of about 29.6%[148]. Investment and R&D - Research and development investment decreased by 24.24% to ¥11,762,236.98 from ¥15,525,001.66[45]. - The company plans to increase investment in the composite materials sector and enhance market share of intermediate products[31]. - The company aims to enhance its management capabilities and R&D investment to improve product competitiveness and market share[74]. Market and Operations - The company focuses on the production and sales of benzene-based intermediates, with products used in pharmaceuticals, pesticides, dyes, and paper chemicals[30]. - The company maintains long-term stable partnerships with global chemical giants, selling products in over 20 countries and regions[30]. - The company is positioned in the middle of the industrial chain, benefiting from the optimization of the fine chemical industry structure[35]. - The company is involved in the production and sale of various chemical products, including electronic chemicals and new materials[69]. Risk Management - The company has acknowledged various macro policy risks and market risks that may impact its operations[6]. - The company is facing macro policy risks due to the ongoing impact of the COVID-19 pandemic on global economic recovery, which may affect product exports[73]. - The company is exposed to exchange rate risks due to a significant portion of its exports being settled in USD, and it will monitor foreign exchange trends closely[74]. - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[75]. Environmental and Social Responsibility - The company is committed to increasing environmental protection investments to meet stricter regulatory standards in the fine chemical industry[75]. - The company has implemented strict environmental monitoring and management measures, ensuring compliance with pollution discharge standards and optimizing existing facilities to improve treatment efficiency[93]. - The company actively engages in social responsibility initiatives, including employment creation, tax contributions, and community support projects such as drinking water improvements and public lighting installations[97]. Shareholder and Equity Information - The company did not distribute cash dividends or bonus shares for the half-year period[80]. - The total number of shares increased to 551,251,422, with an increase of 1,800 shares due to stock options and restricted stock plan exercises[128]. - The largest shareholder, Zhu Shouchan, holds 39.14% of the shares, totaling 161,826,482 shares[133]. - The company has implemented a stock option and restricted stock incentive plan approved on August 25, 2020[128]. Financial Reporting and Compliance - The semi-annual financial report was not audited[104]. - The financial statements reflect the company's financial position and operating results as of June 30, 2021, in accordance with the disclosure requirements[198]. - The financial statements are prepared based on the going concern assumption and comply with the relevant accounting standards[195].